ABSTRACT
Introduction
After tooth extraction, the healing process initiates however, alveolar socket never reaches its previous dimensions either buccolingually or apicocoronally. [1] Additionally, the remaining bone structure after healing undergoes a progressive resorption (catabolic remodeling).
Resorption in the first 6 months after extraction is very fast; however, it slows down and mildly continues for the rest of the person's life. Successful replacement of lost teeth through conventional prosthodontic treatments or implant placement is challenging in an atrophic alveolar ridge. [1] [2] Bone loss compromises the support, retention, stability, and esthetics of dental prosthetics along with the health of the remaining tissues. [3] Bone mass is regulated through the process of remodeling which includes two phases including bone formation by osteoblasts and bone resorption by osteoclasts. Besides, osteoblasts play a role in differentiation of osteoclasts. [4] Recent investigations have demonstrated that central and peripheral nervous sys-tems play a significant role in regulation of bone mass.
[5] Leptin stimulates the sympathetic nervous system [6] [7] and this system intrinsically results in increased expression of RANKL (Receptor activator of nuclear factor kappa-B ligand) receptor on their surface by stimulating the β2-adrenergic receptors on the surface of osteoblasts. The interaction between RANKL and RANK (Receptor activator of nuclear factor kappa-B) on the surface of osteoclasts precursors, transforms them into osteoclasts. [4, 8] Considering the above mentioned findings, various researchers have suggested the use of β2-adrenergic receptor antagonists in prevention or treatment of bone resorption. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Several reports discuss the decreased risk of fracture in those using propranolol which is a non-specific β2-adrenergic receptor antagonist. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Takeda et al. [7] and Bonnet et al. [19] demonstrated that a non-specific β2-adrenergic receptor antagonist like propranolol can enhance bone formation in female rats that had undergone ovariectomy.
If beta-blockers are truly capable of preventing bone resorption in humans, the above mentioned findings can be successfully implemented in oral cavity for extraction socket healing or prevention of progressive alveolar bone resorption following teeth loss. Therefore, the present study was conducted to evaluate the effect of β2-adrenergic receptor antagonists on number of osteoblasts and osteoclasts in alveolar socket following tooth extraction in animal models.
Materials and Method
A total of 40, eight-week old Wistar rats with a mean weight of 270±50 g were selected from an inbred colony. During the study period, the rats were divided into 10 groups of 4 each and kept in an standard cage in a room under controlled conditions with a temperature of 21±2°C and 50%±7% moisture in 12 hours dark and 12 hours light cycle and free access to standard food and water. The rats were brought to the lab one week before the initiation of study to make them acquainted to the environment. The samples were then randomly divided into 2 equal groups of test and control. Color coding system was used for identification of animals to blind the study.
It should be mentioned that the present study was 
Drug administration
First, injectable propranolol (Tolidaroo, Iran), a nonspecific beta-adrenergic receptor antagonist, was dissolved in sterile saline solution right before injection.
It was then injected using an insulin syringe at a dosage of 0.1 mg/kg/day intraperitoneally during the whole study period and at a specific time (11.00 A.M) for all samples in the test group (n=20). The mentioned dosage has been proposed by Bonnet et al. [19] as the lowest dosage capable of preventing bone loss without any cardiovascular effect. The same amount of saline solution was injected to the control group (n=20) with the same method. Injections continued in both groups until their sacrifice ( Figure 1 ).
Figure 1:
The best protocol between control groups (group C) and test groups (group T).
Histological evaluation of extraction socket
At days 7, 14, 21 and 28 post-extraction, 5 samples of any of the case and control groups were randomly selected and sacrificed using diethyl ether (Pars Chemie, Iran). Maxillary bone was resected and immediately stored and fixed in 10% formalin for 48 hours. Then it was preserved in ethylene diamine tetra acetic (EDTA) 10% at 4°C and pH=7.2 for 21 days in order to become decalcified and embedded in paraffin. Tissue blocks were cut serially into 5-µm sections parallel to the sagittal plane using a microtome. We selected sections which contained tooth socket and its surrounding bone structure and were stained with Hematoxylin-Eosin.
Osteoclasts and osteoblasts were counted twice by one blinded researcher at 4 random areas in the alveolar socket wall.
Statistical analysis
Collected data were analyzed using SPSS version 13 software and included descriptive statistics (mean and standard deviation), unpaired t-test and one-way ANOVA using Fisher's protected least significant difference method. p< 0.05 was considered statistically significant.
Results
In the first week following tooth extraction, number of osteoclasts in the control group was significantly higher than the test group receiving propranolol (Table 1 and Figure 2a and 2b).
In the control group, accumulation of osteoclasts was observed not only in the interdental septum but also on the socket floor (Figure 2a and 2b) . Also, a significant increase in number of osteoclasts in both 
Discussion
In the present experimental study, we found that β2 adrenergic receptor antagonists could decrease the number of osteoclast and increase the number of osteoblast during extraction socket healing.
Our study results revealed that in the first week following tooth extraction, when bone resorption is the dominant process, a significant increase was detected in the number of osteoclasts in both groups compared to the following weeks and the number of osteoclasts in the control group was significantly higher than the test group receiving propranolol (p< 0.05).
The mechanism of action of beta-blockers in regulating bone mass is through the stimulation of ost- eogenesis and decreasing bone resorption by preventing the differentiation of osteoclasts through RANK-RANKL system. [7, 19] Since beta-blockers are widely used for treatment of cardiovascular diseases, [13] epidemiologic studies in this respect are feasible. Studies have demonstrated that use of beta-blockers has been associated with lower risk of fractures. Considering the association of sympathetic nervous system with bone metabolism, medical researchers have seriously focused on the application of beta-blockers for prevention and treatment of osteoporosis. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] In dentistry, the relationship between betablockers and bone loss has been the focus of attention for some time now. Kim et al. [20] 
Conclusion
In a conclusion, β2 adrenergic receptor antagonists decrease the number of osteoclasts and increase the number of osteoblasts during extraction socket healing.
